Trials / Completed
CompletedNCT05149222
"REACT-FM-EXT": Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia: An Extension Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Swing Therapeutics, Inc. · Academic / Other
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
This is an extension study of REACT-FM. The primary objective of the study is to assess the response to digital therapy in the treatment of fibromyalgia over an additional 9 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Digital ACT | This is a virtual, single-arm, non-significant risk study. Study participants will receive 9 months of Digital Acceptance and Commitment Therapy (ACT) in addition to their standard care for fibromyalgia. |
Timeline
- Start date
- 2021-11-30
- Primary completion
- 2024-04-14
- Completion
- 2024-04-14
- First posted
- 2021-12-08
- Last updated
- 2024-07-16
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05149222. Inclusion in this directory is not an endorsement.